BackPremier Biomedical Overview

Premier Biomedical Profit Margin

Premier Biomedical (BIEI) has a profit margin of -90.0%, below the sector sector average of 13.16%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

32.61%

As of Jun 2026

Annual Profit Margin (TTM)

-90.00%

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Premier Biomedical (BIEI) FAQ

The latest profit margin for BIEI is -90.0% as of June 2026. That is below the sector sector average of 13.16%. Investors often review this figure alongside Premier Biomedical's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, BIEI currently prints -90.0% for profit margin, while the sector average sits near 13.16%. That is roughly 783.7% below the sector mean. Large gaps often invite a closer look at Premier Biomedical's growth, margins, and balance sheet.

Profit Margin shows how effectively Premier Biomedical converts resources into returns. At -90.0%, BIEI may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BIEI's profit margin (-90.0%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.